Respiro Medical Technology

/res'piro/ verb: to breathe figurative: relief from stress MISSION Respiro is dedicated to revolutionizing the oxygen therapy experience for patients and improving health outcomes by harnessing the power of technology, data-driven insights, and artificial intelligence to develop and introduce a range of innovative products across the respiratory care industry. Respiro represents a paradigm shift in oxygen therapy, ushering in an era of efficiency, precision, and patient-centric care in managing chronic respiratory failure. SIGNIFICANCE Long-term oxygen therapy is the standard of care for chronic hypoxic respiratory failure such as chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD). Over 1.5 million Americans are prescribed oxygen at an annual cost of more than $2.9 billion, with costs increasing every year. The prevalence of chronic hypoxic respiratory failure is rising at 6.2% CAGR, notably affecting younger demographics. Despite its critical importance, oxygen therapy remains one of the most inefficiently administered treatments in medicine, with minimal innovation in recent decades. PRODUCTS/SERVICES Respiro will address the top three challenges of current oxygen therapy treatment: 1. Oxygen Dosing: Prescriptions for oxygen dosing often rely on imprecise estimations rather than tailored assessments of patients' real-world needs, leading to potential adverse effects and suboptimal outcomes. 2. Patient Burden: Patients contend with the cumbersome task of self-dosing oxygen, often without adequate guidance, resulting in challenges in adjusting oxygen levels according to varying activities. This burden not only impacts their physical health but also contributes to heightened levels of anxiety and depression. 3. Disease Monitoring: Current healthcare protocols lack the capability to continuously monitor patients' conditions outside of scheduled appointments, leading to reactive rather than proactive management of their diseases.